A Study Of Magnetic Resonance Lymphangiography

Overview

About this study

The purpose of this study is to determine the safety and feasibility of mapping the axillary and/or inguinal afferent lymphatic pathways with peripheral MR lymphangiography using administration of gadolinium contrast via the microneedle .  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age: 18+

  • Able to provide informed consent

  • GFR ≥ 60 mL/min/1.73 m2

  •  

Exclusion Criteria:

  • Active cancer

  • Prior soft tissue surgery / lymphadenectomy or radiation to the affected extremity or extremities

  • Lymphedema of the affected extremity or extremities

  • Cellulitis or soft tissue infection of the affected extremity or extremities

  • Uncorrectable coagulopathy

  • Contraindication to MRI (i.e. MRI-unsafe pacemaker or other implantable device)

  • Contraindication to gadolinium contrast

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 02/17/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Scott Thompson, M.D., Ph.D.

Contact us for the latest status

Contact information:

Suson Walsh

5072930039

walsh.suson@mayo.edu

More information

Publications

Publications are currently not available